The chemical chaperone tauroursodeoxycholic acid (TUDCA) has been studied in several retinal degeneration models [165,166,167], although its efficacy was found to vary between different studies, even in the presence of the same IRD-causing mutation, namely p.P23H, in the gene encoding rhodopsin. This evidence concerns the gene RHO and retinal degeneration.